Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The primary objective of the study is to evaluate the safe usability of the study drugs, i.e. 4Fluart ID 1 µg haemagglutinin (HA)/0.1 ml QIV and 4Fluart ID 2 µg haemagglutinin (HA)/0.1 ml QIV in terms of safety concerns emerged. The secondary objective of the study is to further assess safety in terms of safety parameters, as well as to assess the immunogenicity of 4Fluart ID 1 µg haemagglutinin (HA)/0.1 ml QIV and 4Fluart ID 2 µg haemagglutinin (HA)/0.1 ml QIV in terms of immunogenicity parameters.
Epistemonikos ID: 2c7dbeb3a581ee0180ed0b6a4cf9e1baf0390557
First added on: May 21, 2024